Pericles Calias

Pericles Calias currently works at Sernova Biotherapeutics, Inc., as Chief Development Officer & Head-R&D from 2025.
Dr. Calias also formerly worked at Genzyme Corp., as Scientist, Kiora Pharmaceuticals, Inc., as Vice President-Research & Development, Pharming Group NV, as Chief Scientific Officer from 2015 to 2016, Sucampo Pharmaceuticals LLC, as Vice President-Global CMC & Product Development from 2017 to 2018, The Charles Stark Draper Laboratory, Inc., as Principal, to-BBB Holding BV, as Chief Scientific Officer, to-BBB technologies BV, as Chief Scientific Officer, Avalo Therapeutics, Inc., as Chief Scientific Officer, Head-R&D from 2018 to 2020, and Revolo Biotherapeutics Ltd., as Chief Operating Officer.
Dr. Calias received his undergraduate degree from Suffolk University and doctorate degree from Tufts University.